

Amneal Pharmaceuticals (NASDAQ:AMRX) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Amneal Pharmaceuticals (NASDAQ:AMRX) through any online brokerage.
Other companies in Amneal Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Amneal Pharmaceuticals has a consensus price target of $17.80.
The stock price for Amneal Pharmaceuticals (NASDAQ: AMRX) is $19.4 last updated November 5, 2026 at 7:25 PM EST.
There are no upcoming dividends for Amneal Pharmaceuticals.
Amneal Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Amneal Pharmaceuticals.
Amneal Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential...